Biotech’s Next Breakthrough Cycle: Dr. David Sans on Catalysts, Capital, and the Comeback of Innovation episode artwork

EPISODE · Oct 21, 2025 · 29 MIN

Biotech’s Next Breakthrough Cycle: Dr. David Sans on Catalysts, Capital, and the Comeback of Innovation

from WTR Small-Cap Spotlight · host Water Tower Research

Send us Fan MailIn this episode of WTR Small-Cap Spotlight, Dr. David Sans, healthcare investment banker, former Novartis oncology researcher, and long-time biotech strategist, joins host Tim Gerdeman, Vice Chair, Co-Founder, and Chief Marketing Officer of Water Tower Research, for an in-depth discussion on the state of the biotech industry. Together, they explore why optimism is returning to the sector, which technologies and therapeutic categories are leading the rebound, and how investment and IPO trends are shaping the next phase of biotech growth.  Discover the bullish underpinnings of The Wall Street Journal article last week titled “Why Biotech’s Rally Can Last This Time”.

Episode metadata supplied by the publisher feed · Published Oct 21, 2025

Embed this episode

NOW PLAYING

Biotech’s Next Breakthrough Cycle: Dr. David Sans on Catalysts, Capital, and the Comeback of Innovation

0:00 29:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of WTR Small-Cap Spotlight?

This episode is 29 minutes long.

When was this WTR Small-Cap Spotlight episode published?

This episode was published on October 21, 2025.

Can I download this WTR Small-Cap Spotlight episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!